Tracked deals
6
6 tracked deals across 2021-2026.
Public Company
Healthcare
Hims & Hers
San Francisco, California, United States
Hims & Hers Health, Inc. (known as Hims & Hers) is a multi-specialty telehealth platform building a virtual front door to the healthcare system. It connects consumers to licensed healthcare professionals for care across conditions including sexual health, hair care, mental health, skincare, primary care and more, with both digital care and related products.
- Focus Areas
- Telehealth / Virtual Care, Digital Health Platform, Online care delivery
- Website
- www.hims.com
Recent pace
1
1 tracked deal announced in the last 12 months.
Deal mix
Buyout
5 buyout · 1 divestiture
Hims & Hers Acquisition Volume by Year
Last 4 years
Actual
Full-year estimate
Supporting Data
Recent Transactions
-
February 19, 2026
- Buyer
- Hims & Hers Health, Inc.
- Target
- Eucalyptus
- Industry
- Healthcare Services
- Location
- New South Wales, Australia
- Type
- Buyout
Hims & Hers Health, Inc. entered into a definitive agreement to acquire Eucalyptus, a digital healthcare company and parent of Juniper and other brands (including Pilot) and operates across Australia, the UK, Germany, with expanding operations in Japan and Canada. The acquisition was later completed, extending Hims & Hers’ global consumer health footprint and expanding offerings such as weight management care in markets like Germany and Canada.
-
June 3, 2025
- Buyer
- Hims & Hers Health, Inc.
- Target
- ZAVA
- Industry
- Healthcare Services
- Location
- England, United Kingdom
- Type
- Buyout
Hims & Hers Health, Inc. agreed to acquire ZAVA, a leading European digital health and telemedicine platform, in an all-cash transaction to accelerate the company's expansion into the UK and launch operations in Germany, France and Ireland. The acquisition brings ZAVA’s ~1.3 million active customers and nearly 2.3 million consultations in 2024 onto Hims & Hers’ platform and is expected to be accretive by 2026.
-
February 21, 2025
- Buyer
- Hims & Hers Health, Inc.
- Target
- US-based peptide facility (unnamed)
- Industry
- Pharmaceuticals
- Location
- California, United States
- Type
- Buyout
Hims & Hers Health, Inc. has acquired a US-based peptide manufacturing facility in California to further verticalize its supply chain and expand domestic capabilities for personalized medications. The acquisition, which closed in early February, strengthens Hims & Hers’ ability to meet growing consumer demand for personalized healthcare and peptide-based treatments.
-
September 12, 2024
- Buyer
- Hims & Hers
- Target
- MedisourceRx
- Seller
- Nivagen Pharmaceuticals
- Industry
- Pharmaceuticals
- Location
- California, United States
- Type
- Divestiture
Hims & Hers has acquired MedisourceRx, the FDA-registered 503B outsourcing facility and business unit of Nivagen Pharmaceuticals. Bourne Partners served as exclusive financial adviser to Nivagen; proceeds from the sale will allow Nivagen to complete a sterile injectables facility in California and advance its pipeline.
-
June 24, 2021
- Buyer
- Hims & Hers Health, Inc.
- Target
- Apostrophe
- Industry
- Healthcare Services
- Location
- California, United States
- Type
- Buyout
Hims & Hers Health, Inc. completed the acquisition of teledermatology specialist Apostrophe to deepen its personalized dermatology offering and integrate Apostrophe's clinical team and compounding pharmacy capabilities. The entire Apostrophe team will join Hims & Hers, with Apostrophe CEO Ben Holber becoming head of Hims & Hers' dermatology business line.
-
- Buyer
- Hims & Hers Health, Inc.
- Target
- Honest Health
- Industry
- Healthcare Services
- Location
- United Kingdom
- Type
- Buyout
Hims & Hers Health, Inc. agreed to acquire London-based vertical health platform Honest Health to accelerate the company's expansion into the United Kingdom and Western Europe. The acquisition adds Honest Health’s hair-loss telehealth clinic and compounding pharmacy/fulfillment capabilities to Hims & Hers’ multi-specialty telehealth platform; financial terms were not disclosed.
Related Acquisition Pages
Selling a company? Get in front of buyers like Hims & Hers
Turn tracked acquisition activity into an outreach-ready buyer list.